Menu Menu Menu
Nice Insight Research
Content Menu
Menu Menu Menu
To Top

Search By Topic

Investment

78 Articles available
Investment

CVS Health Announces $100 Million Community Commitment Following Acquisition Of Aetna

PR-M01-19-NI-044
Investment

New Opioid-alternative Raises $3.25 Million for Phase I Trials

PR-M01-19-NI-037
Investment

Sosei Heptares to Receive US$15 Million Milestone Payment From AstraZeneca With First Partnered Program Moving Towards Phase 2

PR-M01-19-NI-030
Investment

Swiss AI Firm Raises Funds for Entry into U.S.

PAO-M01-19-NI-011
Investment

Antengene Benefits from Second-Round Financing

PAO-M01-19-NI-008
Investment

Biotech Company Stealth BioTherapeutics Files for IPO

PAO-M01-19-NI-007
Investment

Vedanta Increases Investment

PAO-M01-19-NI-004
Investment

China SXT Pharmaceuticals, Inc. Announces First Closing of Initial Public Offering

PR-M01-19-NI-007
Investment

Connect Biopharmaceuticals Completes $55 Million Series B Financing to Accelerate Clinical Development of Novel Immune Modulators

PR-M01-19-NI-005
Investment

Biohaven Announces Closing Of $144M Public Offering Of Common Shares, Including Full Exercise Of Underwriters' Option To Purchase Additional Shares

PR-M12-18-NI-084
Investment

GenEdit Closes $8.5 million Series Seed Financing

PR-M12-18-NI-056
Bayer

Cutbacks and Divestitures Planned at Bayer

PAO-M12-18-NI-004
Finance

Kodiak Sciences Announces Third Quarter 2018 Financial Results and Recent Business Highlights

PR-M11-18-NI-071
Innovation

NIH $1.4M Grant Supports Study into Precision Bioelectronic Medicine

PR-M11-18-NI-057
Investment

NextCure Bags $40 Million from Eli Lilly

PAO-M11-18-NI-010
Financial Results

Trovagene Announces Third Quarter 2018 Highlights and Financial Results

PR-M11-18-NI-037
Cell and Gene Therapy

Oxford Nanopore Technologies Attracts Amgen Investment

PAO-M10-18-NI-031
Investment

Castle Creek Pharma Raises Funding to Repurpose Diacerein

PAO-M10-18-NI-030
Investment

Foreign Investment: Chinese Capital Backs U.S. Biotech

PAP-Q4-18-NI-008
Investment

Qpex Biopharma Announces Closing of $33 Million Series A Financing and Launch of Company to Address Worldwide Problem of Drug-Resistant Infections

PR-M10-18-NI-087
Shareholder

Nxt-ID Issues Shareholder Update

PR-M10-18-NI-083
Pharma Marketing

Pharma’s Big Spending on TV Ads Continues in 2018

PAO-M10-18-NI-022
Investment

New Fund to Focus on India

PAO-M10-18-NI-020
Investment

GSK Funds British Biotech Sitryx

PAO-M10-18-NI-011
Finance

Regeneron to Report Third Quarter 2018 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2018

PR-M10-18-NI-027
Finance

Global Consumer Spending on Cannabis to Rise as Equity Financing of Startups Grows

PR-M10-18-NI-025
Investment

China SXT Pharmaceuticals, Inc. Announces Effectiveness of Registration Statement on Form F-1

PR-M10-18-NI-017
Investment

Aligning with Sponsors for Strategic Growth

PAP-Q3-18-CL-014
Investment

The Biotech Boom

PAP-Q3-18-NI-003
Investment

J&J Anticipates Growth

PAO-M09-18-NI-014
IPO

Ophthalmic Drug Developer Kodiak BioSciences Files for IPO

PAO-M09-18-NI-010
Investment

AxiaMed Announces $12.4 Million Capital Investment Led By Health Enterprise Partners

PR-M09-18-NI-036
Drug Development

Funding Raised for Development of Drug to Treat Symptoms of Menopause

PAO-M09-18-NI-004
Investment

Artios Pharma Receives $84 million in Series B Funding

PAO-M08-18-NI-014
Advertising

Digital Ad Spending by Pharma is Growing Slowly

PAO-M07-18-NI-008
Investment

Women’s Health Company to Expand

PAO-M07-18-NI-007
Investment

Organ-on-a-Chip Company Raises $36 Million

PAO-M07-18-NI-005
Announcement

BioCryst Provides Update on Strategy, Pipeline and Outlook

PR-M07-18-NI-037
Announcement

Bosch Packaging Business Up for Sale

PAO-M07-18-NI-004
Investment

Evonetix Awarded Innovate UK Funding for £1.3 Million Gene Synthesis Project

PR-M07-18-NI-023
Investment

Biogen Exercises Option to Increase Ownership in Samsung Bioepis

PR-M07-18-NI-018
Investment

I-Mab Successfully Raised USD 220 Million in Series C Funding

PR-M07-18-NI-008
Microbiome

Kaleido Raises More Money for Development of Microbiome-Based Therapeutics

PAO-M06-18-NI-021
Investment

Successful IPO for Verrica Pharmaceuticals

PAO-M06-18-NI-018
Cell and Gene Therapy

StrideBio Closes $15.7 Million Series A Financing to Advance Transformational AAV Platform

PR-M06-18-NI-054
Investment

Pfizer Expands Investment in Biotech through Pfizer Ventures

PAO-M06-18-NI-010
Innovation

Funding Round Will Boost Efforts to Develop Antibiotic for Alzheimer’s Disease

PAO-M06-18-NI-005
Investment

Investing in Chinese Pharma Companies Proves Profitable

PR-M05-18-NI-023
Investment

Taking Middle-Market CROs and CDMOs to the Next Level

PAP-Q2-18-CL-003
Used Equipment

With Expertise Comes Security

PA-M05-18-CL-001
IPO

WuXi AppTec Announces Listing of Initial Public Offering of Common Stock on Shanghai Stock Exchange

PR-M05-18-NI-037
Investment

Novasep Invests €10M in "SeneFill," Its New Facility for Commercial Aseptic Fill & Finish Operations

PR-M05-18-NI-028
Earnings

Allergan to Report First Quarter 2018 Earnings and Host Conference Call and Webcast

PR-M04-18-NI-012
Cell and Gene Therapy

Oxford BioMedica is Making Big Moves

PAO-M03-18-NI-012
Servier

Servier Reports Year-On-Year Growth

PAO-M02-18-NI-024
Antibiotic-Resistant

ABAC Therapeutics Announces €16 Million Series A to Develop Therapeutic Solutions to Fight Antibiotic-Resistant Bacteria

PR-M02-18-NI-78
Investment

China Invests Heavily in Western Biotech

PAO-M02-18-NI-013
Investment

Polpharma Group Gets Digital

PAO-M02-18-NI-008
Investment

Dracen Pharmaceuticals Raises Over $40 million

PAO-M02-18-NI-007
Investment

Charles River Laboratories Makes Investments in High-Throughput Screening Infrastructure

PR-M02-18-NI-017
Financing

Engine Biosciences Raises $10 Million in Seed Financing to Accelerate Drug Discovery Using Genomics and Artificial Intelligence

PR-M02-18-NI-015
Market Prediction

Focal Segmental Glomerulosclerosis Market to Reach US$15.83 Billion by 2025, Globally: Transparency Market Research

PR-M01-18-NI-093
Investment

Contract Research Organization Growth and Investment

APR-M10-17-NI-001
Big Data

Genomics Firm Attracts High-Tech Investments

PAO-M01-18-NI-015
Expanded Capacity

Abzena Takes on New Facilities in Cambridge, UK and San Diego

PR-M01-18-NI-013
Investment

Boehringer Ingelheim Demonstrates Continuous Commitment to Its Venture Fund and Fostering Innovation by More than Doubling Funding to 250 M€

PR-M01-18-NI-010
Investment

Transporters Targeting Cell’s Metabolic Gates Win Financing

PAO-M12-17-NI-037
Investment

FUJIFILM Plans $1 Billion Capacity Expansion in U.S., U.K.

PAO-M11-17-NI-029
Expanded Capacity

AbbVie Starts Up New Mammalian Cell-Culture Production Facility in Singapore

PAO-M11-17-NI-019
Expanded Capacity

Eli Lilly Expands Insulin Production Capacity in Indiana

PAO-M11-17-NI-018
BIO International

Attracting Investors and Shortening Development Times

James C. Greenwood, President & CEO, Biotechnology Innovation Organization (BIO)

PTV-M06-17-BIO-016
Neuroprosthetics

Study Projects an $18 Billion Neuroprosthetics Market by 2028

PAO-M08-17-NI-022
Growth Strategy

Boehringer Ingelheim Achieves Good Growth in the First Half of 2017

PR-M08-17-NI-004
API

Cambrex Invests in New Highly Potent API Manufacturing Capacity

PAO-M08-17-NI-016
Investment

Chinese Genetics Company Completes Successful IPO

PAO-M07-17-NI-032
Pharma

Top Biotech Companies at Home in Ireland

PAO-M05-17-NI-035
Equipment

Novel Equipment Solutions: Leading to Manufacturing Efficiency and Productivity

PAP-Q03-16-IR-001

Antibody-Drug Conjugate: Do We Understand The Capital Investment In Our Staff?

PAP-Q02-16-RT-003
×